Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;94:14-18

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miwa, K.
Right arrow Articles by Inoue, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miwa, K.
Right arrow Articles by Inoue, H.

(Circulation. 1996;94:14-18.)
© 1996 American Heart Association, Inc.


Articles

Vitamin E Deficiency in Variant Angina

Kunihisa Miwa, MD; Yuko Miyagi, MD; Akihiko Igawa, MD; Keiko Nakagawa, MD; Hiroshi Inoue, MD

the 2nd Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama 930-01, Japan.

Correspondence to Kunihisa Miwa, MD, 2nd Department of Internal Medicine, Toyama Medical and Pharmaceutical University, 2630 Sugitani, Toyama 930-01, Japan.

Background Oxidative modification of LDL has been suggested to increase coronary vasoreactivity to agonists. A deficiency of vitamin E, a major antioxidant, may be related to the occurrence of coronary artery spasm.

Methods and Results Vitamin E levels were determined with the use of high-performance liquid chromatography in normolipidemic subjects, including 29 patients with active variant angina (group 1), 13 patients with inactive stage of variant angina without anginal attacks during the past 6 months (group 2), 32 patients with a significant (>75%) organic coronary stenosis and stable effort angina (group 3), and 30 patients without coronary artery disease (group 4). Total lipid levels in blood were calculated as total cholesterol plus triglyceride levels. The plasma {alpha}-tocopherol levels as well as {alpha}-tocopherol/lipids were significantly lower in group 1 than in groups 2 through 4. Also, the plasma {gamma}-tocopherol levels were significantly lower in group 1 than in groups 2 through 4. The vitamin E levels were not significantly different between group 1 patients with and those without a significant organic stenosis. In group 1, both {alpha}- and {gamma}-tocopherol levels were significantly elevated after a >=6-month angina-free period. The {alpha}-tocopherol levels in the LDL fraction were significantly lower in group 1 than in group 4. Plasma {alpha}-tocopherol levels were significantly correlated with those in the LDL fractions. In 6 patients of group 1 still having anginal attacks while receiving calcium channel blockers, the addition of vitamin E acetate (300 mg/d) significantly elevated plasma {alpha}-tocopherol levels and inhibited the occurrence of angina.

Conclusions Plasma vitamin E levels were significantly lower in patients with active variant angina than in subjects without coronary spasm, suggesting an association between vitamin E deficiency and coronary artery spasm.


Key Words: antioxidants • angina • coronary disease • lipoproteins • vasospasm




This article has been cited by other articles:


Home page
ChestHome page
S. Sueda, H. Kohno, H. Fukuda, K. Watanabe, N. Ochi, H. Kawada, and T. Uraoka
Limitations of Medical Therapy in Patients With Pure Coronary Spastic Angina
Chest, February 1, 2003; 123(2): 380 - 386.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Haidari, E. Javadi, M. Kadkhodaee, and A. Sanati
Enhanced Susceptibility to Oxidation and Diminished Vitamin E Content of LDL from Patients with Stable Coronary Artery Disease
Clin. Chem., July 1, 2001; 47(7): 1234 - 1240.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
H. Ogawa, H. Soejima, K. Takazoe, S. Miyamoto, I. Kajiwara, H. Shimomura, T. Sakamoto, M. Yoshimura, K. Kugiyama, M. Kimura, et al.
Increased Autoantibodies Against Oxidized Low-Density Lipoprotein in Coronary Circulation in Patients with Coronary Spastic Angina
Angiology, March 1, 2001; 52(3): 167 - 174.
[Abstract] [PDF]


Home page
J. Nutr.Home page
M. Meydani
Vitamin E and Atherosclerosis: Beyond Prevention of LDL Oxidation
J. Nutr., February 1, 2001; 131(2): 366S - 368.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
K. Miwa, K. Nakagawa, N. Yoshida, Y. Taguchi, and H. Inoue
Lipoprotein(a) is a risk factor for occurrence of acute myocardial infarction in patients with coronary vasospasm
J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1200 - 1205.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. P. Palace, M. F. Hill, F. Farahmand, and P. K. Singal
Mobilization of Antioxidant Vitamin Pools and Hemodynamic Function After Myocardial Infarction
Circulation, January 12, 1999; 99(1): 121 - 126.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Miwa, A. Igawa, K. Nakagawa, T. Hirai, and H. Inoue
Consumption of vitamin E in coronary circulation in patients with variant angina
Cardiovasc Res, January 1, 1999; 41(1): 291 - 298.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Motoyama, H. Kawano, K. Kugiyama, O. Hirashima, M. Ohgushi, R. Tsunoda, Y. Moriyama, Y. Miyao, M. Yoshimura, H. Ogawa, et al.
Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina
J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1672 - 1679.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
M. Hamada, Y. Kazatani, K. Matsuzaki, E. Murakami, Y. Shigematsu, K. Hiwada, and K. Kodama
Clinical Characteristics in Japanese Patients with Coexistent Hypertrophic Cardiomyopathy and Coronary Vasospasm
Angiology, September 1, 1998; 49(9): 849 - 855.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
K. Kugiyama, T. Motoyama, O. Hirashima, M. Ohgushi, H. Soejima, K. Misumi, H. Kawano, Y. Miyao, M. Yoshimura, H. Ogawa, et al.
Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina
J. Am. Coll. Cardiol., July 1, 1998; 32(1): 103 - 109.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Miwa, N. Yoshida, K. Nakagawa, and H. Inoue
High-density lipoprotein particles are large in patients with variant angina
Cardiovasc Res, March 1, 1998; 37(3): 729 - 737.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Watanabe, M. Kakihana, S. Ohtsuka, and Y. Sugishita
Randomized, Double-Blind, Placebo-Controlled Study of Supplemental Vitamin E on Attenuation of the Development of Nitrate Tolerance
Circulation, October 21, 1997; 96(8): 2545 - 2550.
[Abstract] [Full Text]


Home page
CirculationHome page
U. Solzbach, B. Hornig, M. Jeserich, and H. Just
Vitamin C Improves Endothelial Dysfunction of Epicardial Coronary Arteries in Hypertensive Patients
Circulation, September 2, 1997; 96(5): 1513 - 1519.
[Abstract] [Full Text]


Home page
Journal Watch CardiologyHome page
Low Vitamin E Associated with Variant Angina
Journal Watch Cardiology, September 1, 1996; 1996(901): 16 - 16.
[Full Text]


Home page
JWatch GeneralHome page
LOW VITAMIN E ASSOCIATED WITH VARIANT ANGINA
Journal Watch (General), July 16, 1996; 1996(716): 6 - 6.
[Full Text]